Gamco Investors INC. ET AL lifted its position in shares of Integer Holdings Corp (NYSE:ITGR) by 18.0% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 32,131 shares of the medical equipment provider’s stock after buying an additional 4,900 shares during the quarter. Gamco Investors INC. ET AL’s holdings in Integer were worth $2,428,000 at the end of the most recent quarter.
Several other large investors have also recently added to or reduced their stakes in the company. Russell Investments Group Ltd. grew its holdings in shares of Integer by 66.3% during the third quarter. Russell Investments Group Ltd. now owns 90,310 shares of the medical equipment provider’s stock worth $6,811,000 after purchasing an additional 35,994 shares during the last quarter. Palouse Capital Management Inc. grew its holdings in shares of Integer by 32.5% during the third quarter. Palouse Capital Management Inc. now owns 3,834 shares of the medical equipment provider’s stock worth $290,000 after purchasing an additional 941 shares during the last quarter. Sciencast Management LP bought a new stake in shares of Integer during the third quarter worth about $204,000. Texas Permanent School Fund grew its holdings in shares of Integer by 9.1% during the third quarter. Texas Permanent School Fund now owns 22,220 shares of the medical equipment provider’s stock worth $1,679,000 after purchasing an additional 1,852 shares during the last quarter. Finally, Comerica Bank grew its holdings in shares of Integer by 6.4% during the third quarter. Comerica Bank now owns 42,108 shares of the medical equipment provider’s stock worth $3,198,000 after purchasing an additional 2,532 shares during the last quarter. Institutional investors own 98.57% of the company’s stock.
Several analysts have recently weighed in on ITGR shares. ValuEngine cut Integer from a “hold” rating to a “sell” rating in a report on Friday, August 2nd. Northcoast Research reiterated a “buy” rating on shares of Integer in a report on Friday, August 2nd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average target price of $65.76.
ITGR stock traded up $0.56 during trading on Friday, hitting $74.12. The company had a trading volume of 207,312 shares, compared to its average volume of 220,155. The business has a 50-day moving average of $75.55 and a 200-day moving average of $76.73. Integer Holdings Corp has a one year low of $67.72 and a one year high of $92.61. The stock has a market cap of $2.51 billion, a PE ratio of 19.51 and a beta of 1.02. The company has a current ratio of 2.40, a quick ratio of 1.35 and a debt-to-equity ratio of 0.73.
Integer (NYSE:ITGR) last announced its earnings results on Thursday, October 31st. The medical equipment provider reported $1.20 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.06 by $0.14. Integer had a return on equity of 13.47% and a net margin of 8.99%. The business had revenue of $303.59 million for the quarter, compared to analysts’ expectations of $313.78 million. During the same period in the prior year, the business posted $1.06 earnings per share. The firm’s revenue was down .5% on a year-over-year basis. Research analysts forecast that Integer Holdings Corp will post 4.62 EPS for the current year.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Further Reading: Consumer Price Index (CPI)
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corp (NYSE:ITGR).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.